Article
Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers.
Cell stem cell - 6 Apr 2017
Gu Mingxia, Shao Ning-Yi, Sa Silin, Li Dan, Termglinchan Vittavat, Ameen Mohamed, Karakikes Ioannis, Sosa Gustavo, Grubert Fabian, Lee Jaecheol, Cao Aiqin, Taylor Shalina, Ma Yu, Zhao Zhixin, Chappell James, Hamid Rizwan, Austin Eric D, Gold Joseph D, Wu Joseph C, Snyder Michael P, Rabinovitch Marlene
Abstract excerpt
In familial pulmonary arterial hypertension (FPAH), the autosomal dominant disease-causing BMPR2 mutation is only 20% penetrant, suggesting that genetic variation provides modifiers that alleviate the disease. Here, we used comparison of induced pluripotent stem cell-derived endothelial cells (iPSC-ECs) from three families with unaffected mutation carriers (UMCs), FPAH patients, and gender-matched controls to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
